Page last updated: 2024-08-25

octylonium and regorafenib

octylonium has been researched along with regorafenib in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ding, Y; Meng, Q; Shi, L; Wang, H; Xu, Z; Zhang, N; Zhou, H; Zhu, M1

Other Studies

1 other study(ies) available for octylonium and regorafenib

ArticleYear
Otilonium Bromide acts as a selective USP28 inhibitor and exhibits cytotoxic activity against multiple human cancer cell lines.
    Biochemical pharmacology, 2023, Volume: 215

    Topics: Antineoplastic Agents; Cell Line; Colorectal Neoplasms; Humans; Quaternary Ammonium Compounds; Ubiquitin Thiolesterase

2023